103 related articles for article (PubMed ID: 21704101)
1. Incorporation of 4-1BB ligand into an adenovirus vaccine vector increases the number of functional antigen-specific CD8 T cells and enhances the duration of protection against influenza-induced respiratory disease.
Moraes TJ; Lin GH; Wen T; Watts TH
Vaccine; 2011 Aug; 29(37):6301-12. PubMed ID: 21704101
[TBL] [Abstract][Full Text] [Related]
2. Contribution of 4-1BBL on radioresistant cells in providing survival signals through 4-1BB expressed on CD8⁺ memory T cells in the bone marrow.
Lin GH; Edele F; Mbanwi AN; Wortzman ME; Snell LM; Vidric M; Roth K; Hauser AE; Watts TH
Eur J Immunol; 2012 Nov; 42(11):2861-74. PubMed ID: 22886791
[TBL] [Abstract][Full Text] [Related]
3. The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus.
Suda T; Kawano M; Nogi Y; Ohno N; Akatsuka T; Matsui M
Antiviral Res; 2011 Sep; 91(3):252-8. PubMed ID: 21722671
[TBL] [Abstract][Full Text] [Related]
4. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
[TBL] [Abstract][Full Text] [Related]
5. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
6. Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.
Baranowska M; Hauge AG; Hoornaert C; Bogen B; Grødeland G
Vaccine; 2015 Dec; 33(49):6988-96. PubMed ID: 26387432
[TBL] [Abstract][Full Text] [Related]
7. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
[TBL] [Abstract][Full Text] [Related]
8. 4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.
Macdonald DC; Hotblack A; Akbar S; Britton G; Collins MK; Rosenberg WC
J Immunol; 2014 Nov; 193(10):5056-64. PubMed ID: 25305314
[TBL] [Abstract][Full Text] [Related]
9. The effects of preexisting immunity to influenza on responses to influenza vectors in mice.
Langley WA; Bradley KC; Li ZN; Talekar GR; Galloway SE; Steinhauer DA
Vaccine; 2010 Aug; 28(38):6305-13. PubMed ID: 20656032
[TBL] [Abstract][Full Text] [Related]
10. An adenoviral cancer vaccine co-encoding a tumor associated antigen together with secreted 4-1BBL leads to delayed tumor progression.
Ragonnaud E; Andersson AM; Pedersen AE; Laursen H; Holst PJ
Vaccine; 2016 Apr; 34(18):2147-56. PubMed ID: 27004934
[TBL] [Abstract][Full Text] [Related]
11. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection.
Tite JP; Hughes-Jenkins C; O'Callaghan D; Dougan G; Russell SM; Gao XM; Liew FY
Immunology; 1990 Oct; 71(2):202-7. PubMed ID: 2172156
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.
Bodewes R; Kreijtz JH; Hillaire ML; Geelhoed-Mieras MM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Gen Virol; 2010 Jul; 91(Pt 7):1743-53. PubMed ID: 20335492
[TBL] [Abstract][Full Text] [Related]
13. Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus.
Kim MH; Kang JO; Kim JY; Jung HE; Lee HK; Chang J
Antiviral Res; 2019 Mar; 163():19-28. PubMed ID: 30639307
[TBL] [Abstract][Full Text] [Related]
14. Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease.
Lin GH; Sedgmen BJ; Moraes TJ; Snell LM; Topham DJ; Watts TH
J Immunol; 2009 Jan; 182(2):934-47. PubMed ID: 19124736
[TBL] [Abstract][Full Text] [Related]
15. Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection.
Garulli B; Meola M; Stillitano MG; Kawaoka Y; Castrucci MR
Virology; 2007 May; 361(2):274-82. PubMed ID: 17222437
[TBL] [Abstract][Full Text] [Related]
16. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
DeBenedette MA; Wen T; Bachmann MF; Ohashi PS; Barber BH; Stocking KL; Peschon JJ; Watts TH
J Immunol; 1999 Nov; 163(9):4833-41. PubMed ID: 10528184
[TBL] [Abstract][Full Text] [Related]
17. Selection of the same major T cell determinants of influenza nucleoprotein after vaccination or exposure to infectious virus.
Brett SJ; Gao XM; Liew FY; Tite JP
J Immunol; 1991 Sep; 147(5):1647-52. PubMed ID: 1715366
[TBL] [Abstract][Full Text] [Related]
18. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.
Stevenson PG; Hawke S; Bangham CR
J Immunol; 1996 Oct; 157(7):3065-73. PubMed ID: 8816416
[TBL] [Abstract][Full Text] [Related]
19. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
Yi KH; Nechushtan H; Bowers WJ; Walker GR; Zhang Y; Pham DG; Podack ER; Federoff HJ; Tolba KA; Rosenblatt JD
Cancer Res; 2007 Oct; 67(20):10027-37. PubMed ID: 17942937
[TBL] [Abstract][Full Text] [Related]
20. LIGHT is dispensable for CD4+ and CD8+ T cell and antibody responses to influenza A virus in mice.
Sedgmen BJ; Dawicki W; Gommerman JL; Pfeffer K; Watts TH
Int Immunol; 2006 May; 18(5):797-806. PubMed ID: 16569673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
